Real-time · AI · Cross-signal

IntegriChain just made a move. Here's exactly what to do next.

Who to reach, what to say, and why now — on IntegriChain, plus every M&A move, funding round, and exec hire that follows, each with verified, ICP-ranked contacts.

Used by professionals at BlackRock, Oracle, Kleiner Perkins, HubSpot, and other leading firms — built on 10 years of proprietary signal data.

Get the full Deep Dive on IntegriChain — free.

We'll email your report. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Everyone else gives you a piece

✕Crunchbase & PitchBook list the company — No person, no timing, no opener.

✕ZoomInfo & Apollo sell you a contact — No trigger, no reason to reach out now.

✕LinkedIn Sales Navigator shows you people — No real-time signal, no opener.

✕Clay enriches lists you built — No live signal of its own, no who or when.

✕ChatGPT & gen-AI tools answer on a delay — No live data, no verified contact.

Who to contactWhat to sayWhen to reach outWhy now

Only Fundz delivers all four.

IntegriChain Acquires Federal Compliance Solutions to Enhance Pharma's Contracts & Pricing and Gross-to-Net Advisory

PRIVATEJul 09, 2024•almost 2 years ago

Acquiring Company

IntegriChain

Acquired Company

Federal Compliance Solutions

Philadelphia

United StatesBiotechnologyConsulting

Description

IntegriChain, a provider of comprehensive technology, data, consulting, and outsourcing platform for data-driven commercialization, has announced the acquisition of Federal Compliance Solutions (FCS), a leading Pharma advisory and managed services firm. This acquisition creates the industry's deepest team of experts in government pricing and payer/provider contracting, aimed at optimizing commercial performance and addressing regulatory and commercial pressures on net revenue.

Company Information

Company

IntegriChain

Location

Philadelphia, Pennsylvania, United States

About

IntegriChain helps Pharma manufacturers bring their science to market, ensuring patients have affordable, timely, and sustainable access to therapy. We are doing this by building Pharma’s data-driven commercialization platform – from strategy to operational execution. Our unique focus on data, technology, consulting, and outsourcing helps connect the commercial, financial, and operational dimensions of drug access and profitability. IntegriChain enables pharmaceutical innovators to achieve better commercial outcomes by digitalizing daily and recurring business activities and by integrating data and operations across contracting, pricing, channel and distribution, and gross-to-net.

Related People

Choose your plan to reveal verified contacts

Predictive Intelligence

Strategic

ML-powered predictions for IntegriChain's next move

Learn about Strategic plan

M&A Insights

Based on deal data

Integration timeline

70% of M&A integrations take 12-24 months to complete

Tech stack consolidation

83% of merged companies consolidate technology vendors within first year

Post-acquisition investment

Companies increase IT spending by 23% on average after acquisitions

Success factor

M&A deals with strong technology integration plans are 2.5x more likely to succeed